MedTrace Logo

Risk Factors for Enhanced Inflammation to Arthroplasty Wear Particles: Analysis of Cytokine Production and Polymorphisms

NCT02262065 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 195

Last updated 2019-02-27

No results posted yet for this study

Summary

Assessment of cytokine polymorphisms in 100 patients with aseptic complications to arthroplasty as compared to 100 symptom-free arthroplasty patients.

In selected patients additional in-vitro cytokine release assay with peripheral blood mononuclear cells (PBMC) stimulated with different wear particles.

Conditions

  • Allergy
  • Implants

Sponsors & Collaborators

  • Technical University of Munich

    collaborator OTHER

  • University of Rostock

    collaborator OTHER

  • Ludwig-Maximilians - University of Munich

    lead OTHER

Principal Investigators

  • Peter Thomas, Prof. Dr. · Ludwig-Maximilians - University of Munich

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2018-01-31
Completion
2019-02-22

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02262065 on ClinicalTrials.gov